Australia markets closed

Pulmonx Corporation (LUNG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.50+0.07 (+0.94%)
At close: 04:00PM EDT
7.50 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
68,675
68,675
53,662
48,416
32,733
Cost of revenue
17,923
17,923
13,797
12,786
11,531
Gross profit
50,752
50,752
39,865
35,630
21,202
Operating expenses
Research development
18,080
18,080
15,397
13,063
7,460
Selling general and administrative
94,607
94,607
83,105
69,871
46,074
Total operating expenses
112,687
112,687
98,502
82,934
53,534
Operating income or loss
-61,935
-61,935
-58,637
-47,304
-32,332
Interest expense
3,232
3,232
1,066
829
3,181
Total other income/expenses net
-673
-673
-396
-585
3,282
Income before tax
-60,272
-60,272
-58,570
-48,318
-32,018
Income tax expense
571
571
353
343
213
Income from continuing operations
-60,843
-60,843
-58,923
-48,661
-32,231
Net income
-60,843
-60,843
-58,923
-48,661
-32,231
Net income available to common shareholders
-60,843
-60,843
-58,923
-48,661
-32,231
Basic EPS
-1.59
-1.60
-1.59
-1.35
-3.16
Diluted EPS
-1.59
-1.60
-1.59
-1.35
-3.16
Basic average shares
37,097
37,975
37,097
36,129
10,185
Diluted average shares
37,097
37,975
37,097
36,129
10,185